last 4 placings..10 Feb 2019 10:23
22 Dec 2017, Raised £1m @ 4.25p
The funds will be used for advancing the clinical trial of VAL201 and for the pre-clinical progress of other programmes.
4 May 2018, Raised £950k @ 2p
The funds will be used for progressing the clinical trial of VAL201 and for advancing the pre-clinical programmes, VAL101 and VAL301, in their preparatory studies prior to their entering the clinic, as has been previously announced.
14 Sep 2018, Raised £1.15m @ 1.5p
The net proceeds of the placing will be used to extend and expand the scope of the clinical trial of VAL201 to treat prostate cancer and to thereby allow the treatment to more speedily reach its full therapeutic potential and potential anti-cancer impact. The funds will also be used to progress the development of the pre-clinical VAL301 and VAL101 programmes and towards clinical trials.
18 Dec 2018, Raised £500k @ 0.75p
The Directors intend that the net proceeds of the Placing will be used to further expand the scope of the clinical trial of VAL201 to treat prostate cancer and to thereby allow the treatment to more speedily reach its full therapeutic potential and potential anti-cancer impact. The funds will also be used to progress the development of the pre-clinical VAL301 and VAL101 programmes and towards clinical trials.